Statistics
Publications
2
Citations
30
H-Index
2
Active since
2023
Affiliations
Michael Doyel is an author at Virginia Commonwealth University specializing in clinical pharmacology, acute myeloid leukemia therapy, and acute myeloid leukemia treatment.
Publications per year
2023–2024
2
2
Venetoclax with decitabine or azacitidine in the first‐line treatment of acute myeloid leukemia
Ian Bouligny, Graeme Murray, Michael Doyel et al. · eJHaem · 2023 · 18 citations · Full text
Medicine, Hematology, Pharmacology +14
1–2 of 2